Evidence map›Paper›PMID 39538260›Full record

ArticleAlzheimer's research & therapy2024

Correction:

Sébastien Heyer, Maïa Simon, Matthieu Doyen, Ali Mortada, Véronique Roch, Elodie Jeanbert, Nathalie Thilly, Catherine Malaplate, Anna Kearney-Schwartz, Thérèse Jonveaux and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Alzheimer's research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Erratum for
    2024
5 · Who and what money

Authors and funding

12 authors.

Sébastien HeyerDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Maïa SimonDepartment of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
Matthieu DoyenDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Ali MortadaDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Véronique RochDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Elodie JeanbertDepartment of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
Nathalie ThillyDepartment of Methodology, Promotion and Investigation, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
Catherine MalaplateDepartment of Biochemistry, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
Anna Kearney-SchwartzDepartment of Geriatrics, Université de Lorraine, CHRU-Nancy, Nancy, F-54000, France.
Thérèse JonveauxCMRR, University Hospital Nancy, Nancy, F-54000, France.
Aurélie BannayMedical Assessment and Information Department, Université de Lorraine, CHRU-Nancy, Nancy, 54000, France.
Antoine VergerDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France. a.verger@chru-nancy.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39538260
PMCPMC11559186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.